Numinus Archives

Psychedelics News

Numinus

Industry

20 Sep 2023

Numinus Closes Bioscience Lab and Consolidates Clinics

Numinus is ceasing operating activities at Numinus Bioscience and consolidating certain of its clinic operations....

By Microdose NewsDesk

Industry

1 Feb 2023

Numinus Receives Approval for Clinical Trial using Psilocybe Cubensis Tea

Numinus Receives Clinical Trial Approval from Health Canada for Experiential Psychedelic-Assisted Therapy Training using Psilocybe Cubensis Tea...

By Microdose NewsDesk

Finance

2 Dec 2022

Numinus Wellness Reports Q4 2022 and Annual Results

Numinus Wellness has released its Q4 2022 and Annual Results...

By Microdose NewsDesk

Industry

28 Oct 2022

Numinus Launches Ketamine Program for Chronic and Serious Illness

Numinus launches Ketamine for Chronic and Serious Medical Illness Program....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry, Science

10 May 2022

Psychedelics and the State of Mental Health

The final path is yet to be determined, but it seems increasingly clear that psychedelic medicine will play a significant role in the future of mental health....

By Ritika Dubey

Press Releases

25 Jun 2021

Numinus Announces Update to Escrow Release Schedule

VANCOUVER, BC, June 25, 2021 /CNW/ – Numinus Wellness Inc....

By Microdose

Press Releases

24 Jun 2021

Numinus Announces Grant of Stock Options

VANCOUVER, BC, June 24, 2021 /CNW/ – Numinus Wellness Inc....

By Microdose

Press Releases

24 Jun 2021

Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoactive Fungi Species

Process leads to standardized psychedelic extracts that are reproducible, scalable, cost-effective and commercially viable VANCOUVER, BC, June 24, 2021 /CNW/ - Numinus Wellness Inc....

By Microdose

Press Releases

18 Jun 2021

Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange

VANCOUVER, BC, June 18, 2021 /CNW/ - Numinus Wellness Inc....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result